BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26957186)

  • 1. Adapting Technological Interventions to Meet the Needs of Priority Populations.
    Linke SE; Larsen BA; Marquez B; Mendoza-Vasconez A; Marcus BH
    Prog Cardiovasc Dis; 2016; 58(6):630-8. PubMed ID: 26957186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized Weight Management Interventions for Cardiovascular Risk Reduction: A Viable Option for African-American Women.
    Franklin NC; Arena R
    Prog Cardiovasc Dis; 2016; 58(6):595-604. PubMed ID: 26908050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus.
    Dutton GR; Lewis CE
    Prog Cardiovasc Dis; 2015; 58(1):69-75. PubMed ID: 25936906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use of Behavior Change Techniques and Theory in Technologies for Cardiovascular Disease Prevention and Treatment in Adults: A Comprehensive Review.
    Winter SJ; Sheats JL; King AC
    Prog Cardiovasc Dis; 2016; 58(6):605-12. PubMed ID: 26902519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Wild Wild West: A Framework to Integrate mHealth Software Applications and Wearables to Support Physical Activity Assessment, Counseling and Interventions for Cardiovascular Disease Risk Reduction.
    Lobelo F; Kelli HM; Tejedor SC; Pratt M; McConnell MV; Martin SS; Welk GJ
    Prog Cardiovasc Dis; 2016; 58(6):584-94. PubMed ID: 26923067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging modifiable risk factors for cardiovascular disease in women: obesity, physical activity, and sedentary behavior.
    Barnes AS
    Tex Heart Inst J; 2013; 40(3):293-5. PubMed ID: 23914023
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of cardiovascular disease for historically marginalized racial and ethnic groups living with HIV: A narrative review of the literature.
    Muiruri C; Longenecker CT; Meissner EG; Okeke NL; Pettit AC; Thomas K; Velazquez E; Bloomfield GS
    Prog Cardiovasc Dis; 2020; 63(2):142-148. PubMed ID: 32057785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case management to reduce risk of cardiovascular disease in a county health care system.
    Ma J; Berra K; Haskell WL; Klieman L; Hyde S; Smith MW; Xiao L; Stafford RS
    Arch Intern Med; 2009 Nov; 169(21):1988-95. PubMed ID: 19933961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of m-Health Technology for Preventive Interventions to Tackle Cardiometabolic Conditions and Other Non-Communicable Diseases in Latin America- Challenges and Opportunities.
    Beratarrechea A; Diez-Canseco F; Irazola V; Miranda J; Ramirez-Zea M; Rubinstein A
    Prog Cardiovasc Dis; 2016; 58(6):661-73. PubMed ID: 27041078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular Disease Among Women From Vulnerable Populations: A Review.
    Kandasamy S; Anand SS
    Can J Cardiol; 2018 Apr; 34(4):450-457. PubMed ID: 29571426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confluence of Cultural Context and Technological Innovation to Reduce Cardiovascular Disparities in India.
    Sinha SS; Prabhakaran D; Chopra V
    Circ Cardiovasc Qual Outcomes; 2017 Nov; 10(11):. PubMed ID: 29101271
    [No Abstract]   [Full Text] [Related]  

  • 12. Best practice for prevention and treatment of cardiovascular disease through an equity lens: a review.
    Beauchamp A; Peeters A; Tonkin A; Turrell G
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):599-606. PubMed ID: 20562629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Lifestyle Intervention for the Treatment of Diabetes study (LIFT Diabetes): Design and baseline characteristics for a randomized translational trial to improve control of cardiovascular disease risk factors.
    Katula JA; Kirk JK; Pedley CF; Savoca MR; Effoe VS; Bell RA; Bertoni AG;
    Contemp Clin Trials; 2017 Feb; 53():89-99. PubMed ID: 27940180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender, socioeconomic and ethnic/racial disparities in cardiovascular disease: a time for change.
    Ski CF; King-Shier KM; Thompson DR
    Int J Cardiol; 2014 Jan; 170(3):255-7. PubMed ID: 24238906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding of and perceptions towards cardiovascular diseases and their risk factors: a qualitative study among residents of urban informal settings in Nairobi.
    Wekesah FM; Kyobutungi C; Grobbee DE; Klipstein-Grobusch K
    BMJ Open; 2019 Jun; 9(6):e026852. PubMed ID: 31209088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Consumer Physical Activity Trackers as an Intervention Tool in Cardiovascular Disease Prevention and Treatment.
    Hickey AM; Freedson PS
    Prog Cardiovasc Dis; 2016; 58(6):613-9. PubMed ID: 26943981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the health beliefs and lifestyle behaviors of women with previous gestational diabetes.
    Jones EJ; Roche CC; Appel SJ
    J Obstet Gynecol Neonatal Nurs; 2009; 38(5):516-26. PubMed ID: 19883473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avoidable Burden of Cardiovascular Diseases in the Eastern Mediterranean Region: Contribution of Selected Risk Factors for Cardiovascular-Related Deaths.
    Mazloumi E; Poorolajal J; Sarrafzadegan N; Roohafza HR; Faradmal J; Karami M
    High Blood Press Cardiovasc Prev; 2019 Jun; 26(3):227-237. PubMed ID: 31228169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community intervention for cardiovascular disease risk factors in Kalutara, Sri Lanka.
    Gamlath L; Nandasena S; Silva P; Morrell S; Linhart C; Lin S; Sharpe A; Nathan S; Taylor R
    BMC Cardiovasc Disord; 2020 Apr; 20(1):203. PubMed ID: 32345219
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.